Konjac Supplement Alleviated Hypercholesterolemia and Hyperglycemia in Type 2 Diabetic Subjects—A Randomized Double-Blind Trial

Journal of the American College of Nutrition

Volumn 22, Issue 1, 2003, Pages 36-42

  Chen, Hsiao Ling ^a   Chen, Yi Chuan ^a   Liaw, Yung Po ^b   Sheu, Wayne Huey Herng ^c   Tai, Tsai Sung ^c  

^a School of Nutrition   (Taiwan)

^b Department of Public Health ^*  (Taiwan)

^c CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Bile acid; Diabetes; Hypercholesterolemia; Hyperglycemia; Konjac glucomannan

Indexed keywords

FRUCTOSAMINE; KONJAC GLUCOMANNAN; MANNAN; PLACEBO; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BILE FLOW; BODY WEIGHT; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET SUPPLEMENTATION; DIETARY FIBER; DOUBLE BLIND PROCEDURE; FEMALE; GLUCOSE ABSORPTION; GLUCOSE BLOOD LEVEL; HUMAN; HYPERCHOLESTEROLEMIA; HYPERGLYCEMIA; INSULIN RESISTANCE; LIPID BLOOD LEVEL; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; RANDOMIZED CONTROLLED TRIAL;

AMORPHOPHALLUS; BLOOD GLUCOSE; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 2; DOUBLE-BLIND METHOD; FECES; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; HYPERGLYCEMIA; MALE; MANNANS; MIDDLE AGED; PHYTOTHERAPY;

EID: 12244286044     PISSN: 07315724     EISSN: 15411087     Source Type: Journal    
DOI: 10.1080/07315724.2003.10719273     Document Type: Article

References (36)

1. Pasternak RC, Grundy SM, Levy D, Thompson PD: 27th Bethesda Conference: matching the intensity of risk factor management with the hazard for coronary disease events. Task Force Spectrum of risk factors for coronary heart disease. J Am Coll Cardiol 27:978-990, 1996.
2. American Heart Association: "1999 Heart and Stroke Statistics Update." Dallas: American Heart Association, 1999.
3. Department of Health: "Health and Vital Statistics." Taipei: Department of Health, Republic of China, 2000.
4. American Diabetes Association: Nutrition recommendations and principles for people with diabetes mellitus. Diabetes Care 23: S23-S46, 2000.
5. Chandalia M, Garg A, Lutjohann D, Bergmann KV, Grundy S, Brinkley LJ: Beneficial effects of high dietary fiber intake in patients with type 2 diabetes mellitus. New Eng J Med 342:1392-1398, 2000.
6. Wolever TMS, Jenkins DJA: Effect of dietary fiber and foods on carbohydrate metabolism. In Spiller GA (ed): "Dietary Fiber in Human Nutrition," 2nd ed. Boca Raton FL: CRC Press, pp. 111- 152, 1993.
7. Shimahara H, Suzuki H, Sugiyama N, Nisizawa K: Isolation and characterization of oligosaccharides from enzymic hydrolysate of konjac glucomannan. Agric Biol Chem 39:293-299, 1975.
8. Doi K: Effect of konjac fibre (Glucomannan) on glucose and lipids. Eur J Clin Nutr 49:S190-S197, 1995.
9. Arvill A, Bodin L: Effect of short-term ingestion of konjac glucomannan on plasma cholesterol in healthy men. Am J Clin Nutr 61:585-589, 1995.
10. Venter CS, Kruger HS, Vorster HH, Serfontein WJ, Ubbink JB, De Villiers LS: The effects of dietary fibre component konjacglucomannan on plasma cholesterol levels of hypercholesterolemic subjects. Hum Nutr Food Sci Nutr 41F:55-61, 1987.
11. Vuksan V, Jenkins DJA, Spadafora P, Sievenpiper JL, Owen R, Vidgen E, Brighenti F, Josse R, Leiter LA, Bruce-Thompson C: Konjac-mannan (Glucomannan) improves glycemia and other associated risk factors for coronary heart disease in type 2 diabetes. A randomized controlled metabolic trial. Diabetes Care 22:913-919, 1999.
12. Vuksan V, Sievenpiper J, Owen R, Swilley JA, Spadafora P, Jenkins DJA, Vidgen E, Brighenti F, Josse RG, Leiter LA, Xu Z, Novokmet R: Beneficial effects of viscous dietary fiber from konjac-mannan in subjects with the insulin resistance syndrome. Diabetes Care 23:9-14, 2000.
13. National Cholesterol Education Program: second report of the expert panel on detection, evaluation and treatment of high blood cholesterol in adults. Circulation 89:1333-1445, 1994.
14. Williams S (ed): "Official Methods of Analysis of the Association of Official Analytical Chemists," 14th ed. Gaithersburg, MD: AOAC International, pp 260-261, 1984.
15. Williams S (ed): "Official Methods of Analysis of the Association of Official Analytical Chemists," 14th ed. Gaithersburg, MD: AOAC International, p 259, 1984.
16. Williams S (ed): "Official Methods of Analysis of the Association of Official Analytical Chemists," 14th ed. Gaithersburg, MD: AOAC International, p 253, 1984.
17. Williams S (ed): "Official Methods of Analysis of the Association of Official Analytical Chemists," 14th ed. Gaithersburg, MD: AOAC International, p 249, 1984.
18. Department of Health: "Nutrient Composition Data Bank for Food of Taiwan Area." Taipei: Department of Health, Republic of China, 1998.
19. Warnick GR, Nguyen T, Albers JJ: Comparison of improved precipitation methods for quantification of high density lipoprotein cholesterol. Clin Chem 31:217-222, 1985.
20. Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low density lipoprotein cholesterol in plasma, without the use of the preparative ultracentrifuge. Clin Chem 18:499-502, 1972.
21. Huang TC, Chen PC, Wefler V, Raftery A: A stable reagent for the Liebermann-Burchard reaction application to rapid serum cholesterol determination. Anal Chem 33:1405-1407, 1961.
22. Chen H-L, Lu Y-H, Lin J-J, Ko L-Y: Effects of isomaltooligosaccharide on bowel function and nutritional status in constipated elderly men. J Am Coll Nutr 20:1-6, 2001.
23. SAS Institute: SAS/STAT User's Guide, Version 6, 4th ed. Cary NC, SAS Institute, 1989.
24. Ott L: Crossover design. In Ott L (ed): "An Introduction to Statistical Methods and Data Analysis," 3rd ed. Boston: PWS-Kent, pp 802-804, 1988.
25. Hochberg Y: A sharper Bonferroni procedure for multiple test significance. Biometrika 75:800-802, 1988.
26. Pan W-H, Chang Y-H, Wu S-J, Tzeng MS, Kao MD: Nutrition and health survey Taiwan (NAHSIT) 1993-1996: dietary nutrient intakes assessed by 24-hour recall. Nutr Sci J 24:11-37, 1999.
27. Chen H-L, Huang Y-C: Fiber intakes and food selections of the elderly in Taiwan. Nutr, in press, 2003.
28. American Diabetes Association: Management of dyslipidemia in adults with diabetes. Diabetes Care 23:S57-S60, 2000.
29. Ebihara K, Schneeman BO: Interaction of bile acids, phospholipids, cholesterol and triglyceride with dietary fibers in the small intestine of rats. J Nutr 119:1100-1106, 1989.
30. Wu J, Peng SS: Comparison of hypolipidemic effect of refined konjac meal with several common dietary fibers and their mechanisms of action. Biomed Environ Med 10:27-37, 1997.
31. Story JA: Bile acids. In Kritchevsky D, Bonfield C (eds): "Dietary Fiber in Health and Disease." St. Paul, MN: Eagan Press, pp 450-452, 1995.
32. Jenkins AL, Vuksan V, Jenkins DJA: Fiber in the treatment of hyperlipidemia. In Spiller GA (ed): "CRC Handbook of Dietary Fiber in Human Nutrition," 3rd ed. Boca Raton, FL: CRC Press, pp 401-429, 2001.
33. Gallaher CM, Munion J, Hesslink R, Wise J, Gallaher DD: Cholesterol reduction by glucomannan and chitosan is mediated by changes in cholesterol absorption and bile acid and fat excretion in rats. J Nutr 130:2753-2759, 2000.
34. Marlett JA, Hosig KB, Vollendorf NW, Shinnick FL, Haack VS, Story JA: Mechanism of serum cholesterol reduction by oat bran. Hepatology 20:1450-1457, 1994.
35. Aro A, Unsitupa M, Voutilainen E, Hersio K, Korhonen T, Siitonen O: Improved diabetic control and hypocholesterolaemic effect induced by long-term dietary supplementation with guar gum in type 2 (insulin-independent) diabetes. Diabetologia 21:29-33, 1981.
36. Landin K, Holm G, Tengborn L, Smith U: Guar gum improves insulin sensitivity, blood lipids, blood pressure, and fibrinolysis in healthy men. Am J Clin Nutr 56:1061-1065, 1992.